CAH
Cardinal Health (CAH) Stock Analysis
Research Cardinal Health (CAH) with company financials, earnings context, valuation indicators, risk analysis and related market news.
Research record updated: . Individual measures may refer to different reporting periods.
- Ticker
- CAH
- Company
- Cardinal Health
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Market cap
- $54.68B
- Financial data source
- FMP financial statements + FMP cash flow statements + FMP balance sheet + income statements
- Annual revenue (reporting year not supplied)
- $254.25B
- Annual net income (reporting year not supplied)
- $1.71B
- Annual free cash flow (reporting year not supplied)
- $4.53B
- Trailing revenue
- $254.25B
- Trailing net income
- $1.71B
- Total assets
- $57.30B
- Total liabilities
- $60.02B
Cardinal Health (CAH) Stock Analysis research
Review the available company profile, financial history, valuation context and investor signals for Cardinal Health. Compare the reported operating results with the valuation and risk measures below.
The figures are cached research data and can change after new filings, earnings reports or market updates. Verify material facts with primary company disclosures before making an investment decision.
Latest related news
Cardinal Health Extends CVS Distribution Deal Through 2032
Cardinal Health extended its CVS distribution relationship through June 2032 and reaffirmed fiscal 2027 and long-term EPS growth guidance.
Intel’s Terafab Role Offers a Test for Its Foundry Strategy
Intel’s continued Terafab involvement could provide a foundry proof point as high bond yields and fuel costs pressure other sectors.